CrossrefInfokarte
Pretreatment with a gonadotropin-releasing hormone agonist and an aromatase inhibitor may improve outcomes in in vitro fertilization cycles of women with stage I–II endometriosis
F&S Science · 2020-08 · 1 (1) · 98-103
DOI: 10.1016/j.xfss.2020.06.005 ↗Abstract
Kein Abstract verfügbar.
EUVIMED